Literature DB >> 17993004

[Study on adscription of plasma effective constituents of rat after administrated with Paeonia lacliflora and Glycyrrhiza uralensis compound].

Liang Zhang1, De-sheng Xu, Yi Feng.   

Abstract

OBJECTIVE: To study the adscription of plasma effective constituents of rat after oral administration of Paeonia lacliflora and Glycyrrhiza uralensis compound.
METHOD: Based on the established HPLC analytical method of plasma effective constituents, analysis and comparison were carried out among HPLC profiles of plasma samples obtained after oral administration of different ingredient preparations such as P. lacliflora and G. uralensis compound, single ingredient and all the preparations. The adscription of plasma effective compounds were identified. RESULT: Eighteen compounds were detected under this method, three of which are metabolites and thirteen are original forum of compounds contained in P. laclflora and G. uralensis compound.
CONCLUSION: This method is simple, accurate and stable, it could be used to analyze plasma effective constituents of P. lacliflora and G. uralensis compound. Affirmation of plasma effective compounds is the basis of to explore active compounds of P. lacliflora and G. uralensis compound.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17993004

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

1.  Pharmacokinetics of characteristic effective ingredients from individual and combination Shaoyao and Gancao treatment in rats using HPLC fingerprinting.

Authors:  Lan Shen; Rong-wan Hu; Xiao Lin; Wen-juan Cong; Yan-long Hong; Yi Feng; De-sheng Xu; Ke-feng Ruan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-10-11       Impact factor: 2.441

2.  Estrogen-like neuroprotection of isopsoralen against spinal cord injury through estrogen receptor ERα.

Authors:  Xiao-Ming Li; Qi Yang; Xu-Bo Li; Qiang Cheng; Kun Zhang; Jing Han; Jian-Ning Zhao; Gang Liu; Ming-Gao Zhao
Journal:  Metab Brain Dis       Date:  2016-09-26       Impact factor: 3.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.